XTNT — Xtant Medical Holdings Income Statement
0.000.00%
Last trade - 00:00- $67.33m
- $67.48m
- $133.93m
Annual income statement for Xtant Medical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 55.3 | 58 | 91.3 | 117 | 134 |
| Cost of Revenue | |||||
| Gross Profit | 32.5 | 32.1 | 55.5 | 68.2 | 84.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 59.1 | 64.7 | 89.8 | 129 | 123 |
| Operating Profit | -3.85 | -6.75 | 1.54 | -12.1 | 10.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.85 | -8.42 | -1.04 | -16.3 | 7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.85 | -8.48 | 0.66 | -16.4 | 4.97 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.85 | -8.48 | 0.66 | -16.4 | 4.97 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.85 | -8.48 | 0.66 | -16.4 | 4.97 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.057 | -0.09 | -0.055 | -0.123 | 0.018 |